HUP2100370A1 - Vitamin d3 and use of a pharmaceutical composition comprising vitamin d3 - Google Patents

Vitamin d3 and use of a pharmaceutical composition comprising vitamin d3

Info

Publication number
HUP2100370A1
HUP2100370A1 HU2100370A HUP2100370A HUP2100370A1 HU P2100370 A1 HUP2100370 A1 HU P2100370A1 HU 2100370 A HU2100370 A HU 2100370A HU P2100370 A HUP2100370 A HU P2100370A HU P2100370 A1 HUP2100370 A1 HU P2100370A1
Authority
HU
Hungary
Prior art keywords
vitamin
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
HU2100370A
Other languages
Hungarian (hu)
Inventor
Szamosujvari Pal Miklos Dr
Szamosujvarine Dr Javor Judit Dr
Pal Szamosujvari
Original Assignee
Pharma Patent Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Patent Kft filed Critical Pharma Patent Kft
Priority to HU2100370A priority Critical patent/HUP2100370A1/en
Publication of HUP2100370A1 publication Critical patent/HUP2100370A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5939,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
HU2100370A 2021-10-28 2021-10-28 Vitamin d3 and use of a pharmaceutical composition comprising vitamin d3 HUP2100370A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU2100370A HUP2100370A1 (en) 2021-10-28 2021-10-28 Vitamin d3 and use of a pharmaceutical composition comprising vitamin d3

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU2100370A HUP2100370A1 (en) 2021-10-28 2021-10-28 Vitamin d3 and use of a pharmaceutical composition comprising vitamin d3

Publications (1)

Publication Number Publication Date
HUP2100370A1 true HUP2100370A1 (en) 2023-05-28

Family

ID=89993449

Family Applications (1)

Application Number Title Priority Date Filing Date
HU2100370A HUP2100370A1 (en) 2021-10-28 2021-10-28 Vitamin d3 and use of a pharmaceutical composition comprising vitamin d3

Country Status (1)

Country Link
HU (1) HUP2100370A1 (en)

Similar Documents

Publication Publication Date Title
IL275704A (en) Oral pharmaceutical formulation comprising cannabinoids and poloxamer
EP4146198A4 (en) Novel compositions of matter and pharmaceutical compositions
EP4149470A4 (en) Pharmaceutical formulations and uses thereof
EP4183391A4 (en) Pharmaceutical composition and use thereof
IL311331A (en) Pharmaceutical composition and use thereof
EP4106870A4 (en) Compositions and therapeutic uses of cannabidiol
EP4073071A4 (en) Use and pharmaceutical composition of phenylisoxazolyl methylene-naphthalene-ether derivatives
EP3969054A4 (en) Oil-soluble drug containing compositions and methods of use thereof
EP4103539A4 (en) Compounds and pharmaceutical uses thereof
SG11202112487QA (en) Collagen peptide-based medicament compositions and devices and methods of production and use thereof
HUP2100370A1 (en) Vitamin d3 and use of a pharmaceutical composition comprising vitamin d3
GB202010230D0 (en) Pharmaceutical formulation
EP3849532A4 (en) Sustained-release pharmaceutical compositions comprising of a sedative drug and uses thereof
EP4180040A4 (en) Pharmaceutical composition and application thereof
GB202217964D0 (en) Pharmaceutical and cosmetic compositions comprising secretomes
IL297081A (en) Pharmaceutical formulation
EP4129283A4 (en) Pharmaceutical combination and use thereof
IL287912A (en) Pharmaceutical composition of a weak acid drug and methods of administration
IL283320A (en) Single-dose use of a composition comprising a particular mixture of grape extract and blueberry extract
EP4115902A4 (en) Combined use of ctb006 and ponatinib
IL271875B (en) Application of totarol and pharmaceutical composition containing totarol
ZA202109873B (en) Application of pectolinarin in preparation of anti-osteosarcoma drugs
GB202316715D0 (en) Medicinal products and uses thereof
EP4100020A4 (en) Aspacytarabine pharmaceutical compositions and uses thereof
EP4129282A4 (en) Pharmaceutical combination and use thereof

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished